The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors.
The treatment of chronic, nonhealing wounds is discussed. The authors have successfully utilized locally acting growth factors as an adjunct to aggressive, comprehensive management in a clinical setting. At the Holmes Regional Wound Care Center, wounds with an average duration of 75 weeks at presentation were 100% epithelialized in an average of 10 weeks of therapy. The use of topical PROCUREN, or autologous platelet-derived wound healing factors (PDWHF) is introduced to the podiatric literature.
Ganio
C
C
Holmes Regional Wound Care Center.
Tenewitz
F E
FE
Wilson
R C
RC
Moyles
B G
BG
D001804:Blood Transfusion, Autologous; D004311:Double-Blind Method; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use*; D012189:Retrospective Studies; D014945:Wound Healing / Q000187:drug effects*; D014947:Wounds and Injuries / Q000628:therapy*
D010982:Platelet-Derived Growth Factor